Protagonist Therapeutics (PTGX) P/E (2016 - 2026)
Protagonist Therapeutics (PTGX) P/E from Sep 30, 2016 to Jul 20, 2026. The TTM Protagonist Therapeutics (PTGX) P/E is -72.97. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Protagonist Therapeutics (PTGX)
| Year | P/E | Change |
|---|---|---|
| 2026 | -72.97 | +74.37% |
| 2025 | -41.85 | -600.48% |
| 2024 | 8.36 | -195.14% |
| 2023 | -8.79 | +115.93% |
| 2022 | -4.07 | -68.16% |
| 2021 | -12.78 | +20.42% |
| 2020 | -10.61 | +354.25% |
| 2019 | -2.34 | -39.95% |
| 2018 | -3.89 | -49.84% |
| 2017 | -7.76 | -85.06% |
| 2016 | -51.91 | N/A |
Comparison Protagonist Therapeutics (PTGX) P/E with competitors
Protagonist Therapeutics (PTGX) P/E is -72.97.